Payal Dave

Payal Dave practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Payal Dave's NPI, 1689786501, was assigned on August 31, 2006. Payal Dave graduated from Virginia Commonwealth University, School of Medicine in 2001. Payal Dave holds New Jersey license 25MA07756100.

Payal Dave's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Payal Dave also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Payal Dave's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. The medical group on file is Rutgers Health - Robert Wood Johnson Medical Group. Dmand AI also links Payal Dave to 2 more medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Payal Dave practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Payal Dave's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Payal Dave is licensed in New Jersey.

CMS data shows 139 Medicare services from Payal Dave across 4 procedure codes in 2024, for 51 Medicare patients. Medicare paid $13,268 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 51 Medicare patients who saw Payal Dave in 2024. The largest group is 75 to 84, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Payal Dave's median patient age at 70, with 47% women.

In 2024, Payal Dave wrote 527 Medicare Part D claims for 87 patients. 77% of them were for generic drugs. CMS names the drug for 266 of them, across 13 drugs with 11 or more claims each, at $39,515 in total drug cost. In 2023, CMS named 325 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Payal Dave for performance year 2024, reported through an alternative payment model (APM). Payal Dave accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Payal Dave, published from 2023 to 2025. Payal Dave has published most often in J Gen Intern Med. Payal Dave's most frequent co-authors are Ranita Sharma, MD, Andrew Raif Azab, MD and Russell Andrew Caratenuto, MD.

CMS Open Payments shows 4 general payments to Payal Dave from 1 drug or device company from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $72.

Payal Dave graduated from Virginia Commonwealth University, School of Medicine in 2001.